Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Arkh Patol ; 59(4): 28-31, 1997.
Artigo em Russo | MEDLINE | ID: mdl-9334152

RESUMO

Pathomorphosis of Ewing's tumors after the combined treatment is studied with the use of light and electron microscopy, DNA-flow cytometry. Necrosis and apoptosis of tumor cells produced by the therapy are characterized. Therapeutic forms of tumor cells representing hyperaneuploid population delayed at the G2-level of the cell cycle are described.


Assuntos
Antineoplásicos/uso terapêutico , Cuidados Pós-Operatórios/métodos , Sarcoma de Ewing/terapia , Apoptose , Terapia Combinada , Citometria de Fluxo , Humanos , Microscopia Eletrônica , Mitose , Necrose , Sarcoma de Ewing/patologia , Sarcoma de Ewing/radioterapia
2.
Vopr Onkol ; 37(4): 441-6, 1991.
Artigo em Russo | MEDLINE | ID: mdl-1887641

RESUMO

Receptors of estrogens (ER), progesterone (PR), glucocorticoids (GR) and androgens (AR) were assayed in samples obtained from 142 patients with malignant melanoma. GR were observed most often (57% of cases), the percentage being significantly lower for ER (25%) and PR (18%) and extremely low for AR (4%). The occurrence of GR was significantly higher in metastasis to lymph nodes (69%) and soft tissue (67%) as compared to primary tumor (39%). It was higher in acro-lentiginous melanoma (83%) than in superficially extending (30%) or nodular one (33%). GR occurrence rose with the increase in level of invasion (from 30% for level III to 71% for level V) and tumor thickness. In application of adjuvant chemotherapy, patients with GR--negative tumors tended to survive better than those with GR--positive tumors whereas in the chemotherapy-naive group, GR--positive tumors carried better prognosis.


Assuntos
Citoplasma/química , Melanoma/química , Receptores de Esteroides/análise , Neoplasias Cutâneas/química , Adulto , Idoso , Feminino , Humanos , Masculino , Melanoma/tratamento farmacológico , Melanoma/mortalidade , Pessoa de Meia-Idade , Prognóstico , Receptores Androgênicos/análise , Receptores de Estrogênio/análise , Receptores de Glucocorticoides/análise , Receptores de Progesterona/análise , Neoplasias Cutâneas/tratamento farmacológico , Neoplasias Cutâneas/mortalidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...